+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neurodegenerative Diseases Therapeutics Market 2025-2029- Product Image
Neurodegenerative Diseases Therapeutics Market 2025-2029- Product Image
New

Neurodegenerative Diseases Therapeutics Market 2025-2029

  • PDF Icon

    Report

  • 251 Pages
  • April 2025
  • Region: Global
  • TechNavio
  • ID: 5578826
1h Free Analyst Time
REQUEST FREE SAMPLE
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The neurodegenerative diseases therapeutics market is forecasted to grow by USD 24.85 billion during 2024-2029, accelerating at a CAGR of 9.1% during the forecast period. The report on the neurodegenerative diseases therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by strong drug development pipeline, high research funding on neurodegenerative diseases, and availability of highly sensitive diagnostic modalities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The neurodegenerative diseases therapeutics market is segmented as below:

By Indication

  • Multiple sclerosis
  • Alzheimers disease
  • Parkinsons disease
  • Huntingtons disease
  • Others

By Drug Class

  • Immunomodulators
  • Interferons
  • Decarboxylase inhibitors
  • Dopamine agonists
  • Others

By Route Of Administration

  • Oral
  • Injection
  • Transdermal

By End-user

  • Hospital pharmacy
  • Retail pharmacy
  • Online pharmacy

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increase in aging population as one of the prime reasons driving the neurodegenerative diseases therapeutics market growth during the next few years. Also, improved understanding of genetic basis and molecular pathology of neurodegenerative diseases and high economic burden will lead to sizable demand in the market.

The report on the neurodegenerative diseases therapeutics market covers the following areas:

  • Neurodegenerative Diseases Therapeutics Market sizing
  • Neurodegenerative Diseases Therapeutics Market forecast
  • Neurodegenerative Diseases Therapeutics Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurodegenerative diseases therapeutics market vendors that include AB Science SA, AbbVie Inc., Acadia Pharmaceuticals Inc., AstraZeneca Plc, Biogen Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, H Lundbeck AS, Johnson and Johnson Services Inc., Merck and Co. Inc., Mitsubishi Chemical Corp., Novartis AG, Pfizer Inc., Sanofi SA, and Teva Pharmaceutical Industries Ltd. Also, the neurodegenerative diseases therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Indication
Executive Summary - Chart on Market Segmentation by Drug Class
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Neurodegenerative Diseases Therapeutics Market 2019 - 2023
Historic Market Size - Data Table on Global Neurodegenerative Diseases Therapeutics Market 2019 - 2023 ($ million)
5.2 Indication segment analysis 2019 - 2023
Historic Market Size - Indication Segment 2019 - 2023 ($ million)
5.3 Drug Class segment analysis 2019 - 2023
Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
5.4 Route of Administration segment analysis 2019 - 2023
Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.5 End-user segment analysis 2019 - 2023
Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.6 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.7 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI in global neurodegenerative diseases therapeutics market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Indication
8.1 Market segments
Chart on Indication - Market share 2024-2029 (%)
Data Table on Indication - Market share 2024-2029 (%)
8.2 Comparison by Indication
Chart on Comparison by Indication
Data Table on Comparison by Indication
8.3 Multiple sclerosis - Market size and forecast 2024-2029
Chart on Multiple sclerosis - Market size and forecast 2024-2029 ($ million)
Data Table on Multiple sclerosis - Market size and forecast 2024-2029 ($ million)
Chart on Multiple sclerosis - Year-over-year growth 2024-2029 (%)
Data Table on Multiple sclerosis - Year-over-year growth 2024-2029 (%)
8.4 Alzheimers disease - Market size and forecast 2024-2029
Chart on Alzheimers disease - Market size and forecast 2024-2029 ($ million)
Data Table on Alzheimers disease - Market size and forecast 2024-2029 ($ million)
Chart on Alzheimers disease - Year-over-year growth 2024-2029 (%)
Data Table on Alzheimers disease - Year-over-year growth 2024-2029 (%)
8.5 Parkinsons disease - Market size and forecast 2024-2029
Chart on Parkinsons disease - Market size and forecast 2024-2029 ($ million)
Data Table on Parkinsons disease - Market size and forecast 2024-2029 ($ million)
Chart on Parkinsons disease - Year-over-year growth 2024-2029 (%)
Data Table on Parkinsons disease - Year-over-year growth 2024-2029 (%)
8.6 Huntingtons disease - Market size and forecast 2024-2029
Chart on Huntingtons disease - Market size and forecast 2024-2029 ($ million)
Data Table on Huntingtons disease - Market size and forecast 2024-2029 ($ million)
Chart on Huntingtons disease - Year-over-year growth 2024-2029 (%)
Data Table on Huntingtons disease - Year-over-year growth 2024-2029 (%)
8.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.8 Market opportunity by Indication
Market opportunity by Indication ($ million)
Data Table on Market opportunity by Indication ($ million)
9 Market Segmentation by Drug Class
9.1 Market segments
Chart on Drug Class - Market share 2024-2029 (%)
Data Table on Drug Class - Market share 2024-2029 (%)
9.2 Comparison by Drug Class
Chart on Comparison by Drug Class
Data Table on Comparison by Drug Class
9.3 Immunomodulators - Market size and forecast 2024-2029
Chart on Immunomodulators - Market size and forecast 2024-2029 ($ million)
Data Table on Immunomodulators - Market size and forecast 2024-2029 ($ million)
Chart on Immunomodulators - Year-over-year growth 2024-2029 (%)
Data Table on Immunomodulators - Year-over-year growth 2024-2029 (%)
9.4 Interferons - Market size and forecast 2024-2029
Chart on Interferons - Market size and forecast 2024-2029 ($ million)
Data Table on Interferons - Market size and forecast 2024-2029 ($ million)
Chart on Interferons - Year-over-year growth 2024-2029 (%)
Data Table on Interferons - Year-over-year growth 2024-2029 (%)
9.5 Decarboxylase inhibitors - Market size and forecast 2024-2029
Chart on Decarboxylase inhibitors - Market size and forecast 2024-2029 ($ million)
Data Table on Decarboxylase inhibitors - Market size and forecast 2024-2029 ($ million)
Chart on Decarboxylase inhibitors - Year-over-year growth 2024-2029 (%)
Data Table on Decarboxylase inhibitors - Year-over-year growth 2024-2029 (%)
9.6 Dopamine agonists - Market size and forecast 2024-2029
Chart on Dopamine agonists - Market size and forecast 2024-2029 ($ million)
Data Table on Dopamine agonists - Market size and forecast 2024-2029 ($ million)
Chart on Dopamine agonists - Year-over-year growth 2024-2029 (%)
Data Table on Dopamine agonists - Year-over-year growth 2024-2029 (%)
9.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
9.8 Market opportunity by Drug Class
Market opportunity by Drug Class ($ million)
Data Table on Market opportunity by Drug Class ($ million)
10 Market Segmentation by Route of Administration
10.1 Market segments
Chart on Route of Administration - Market share 2024-2029 (%)
Data Table on Route of Administration - Market share 2024-2029 (%)
10.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
10.3 Oral - Market size and forecast 2024-2029
Chart on Oral - Market size and forecast 2024-2029 ($ million)
Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Chart on Oral - Year-over-year growth 2024-2029 (%)
Data Table on Oral - Year-over-year growth 2024-2029 (%)
10.4 Injection - Market size and forecast 2024-2029
Chart on Injection - Market size and forecast 2024-2029 ($ million)
Data Table on Injection - Market size and forecast 2024-2029 ($ million)
Chart on Injection - Year-over-year growth 2024-2029 (%)
Data Table on Injection - Year-over-year growth 2024-2029 (%)
10.5 Transdermal - Market size and forecast 2024-2029
Chart on Transdermal - Market size and forecast 2024-2029 ($ million)
Data Table on Transdermal - Market size and forecast 2024-2029 ($ million)
Chart on Transdermal - Year-over-year growth 2024-2029 (%)
Data Table on Transdermal - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)
11 Market Segmentation by End-user
11.1 Market segments
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
11.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
11.3 Hospital pharmacy - Market size and forecast 2024-2029
Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
11.4 Retail pharmacy - Market size and forecast 2024-2029
Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
11.5 Online pharmacy - Market size and forecast 2024-2029
Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million)
Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million)
Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
11.6 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
12 Customer Landscape
12.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
13.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
13.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
13.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
13.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
13.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
13.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
13.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
13.8 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
13.9 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
13.10 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
13.11 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
13.12 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
13.13 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
13.14 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
13.15 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
13.16 South Korea - Market size and forecast 2024-2029
Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Chart on South Korea - Year-over-year growth 2024-2029 (%)
Data Table on South Korea - Year-over-year growth 2024-2029 (%)
13.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
14 Drivers, Challenges, and Opportunity/Restraints
14.1 Market drivers
14.2 Market challenges
14.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
14.4 Market opportunities/restraints
15 Competitive Landscape
15.1 Overview
15.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
15.3 Landscape disruption
Overview on factors of disruption
15.4 Industry risks
Impact of key risks on business
16 Competitive Analysis
16.1 Companies profiled
Companies covered
16.2 Company ranking index
Company ranking index
16.3 Market positioning of companies
Matrix on companies position and classification
16.4 AB Science SA
AB Science SA - Overview
AB Science SA - Product / Service
AB Science SA - Key offerings
SWOT
16.5 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
SWOT
16.6 Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc. - Overview
Acadia Pharmaceuticals Inc. - Product / Service
Acadia Pharmaceuticals Inc. - Key offerings
SWOT
16.7 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
SWOT
16.8 Biogen Inc.
Biogen Inc. - Overview
Biogen Inc. - Product / Service
Biogen Inc. - Key offerings
SWOT
16.9 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
SWOT
16.10 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
SWOT
16.11 H Lundbeck AS
H Lundbeck AS - Overview
H Lundbeck AS - Product / Service
H Lundbeck AS - Key offerings
SWOT
16.12 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
SWOT
16.13 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
SWOT
16.14 Mitsubishi Chemical Corp.
Mitsubishi Chemical Corp. - Overview
Mitsubishi Chemical Corp. - Business segments
Mitsubishi Chemical Corp. - Key offerings
Mitsubishi Chemical Corp. - Segment focus
SWOT
16.15 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
16.16 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
16.17 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
SWOT
16.18 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
SWOT
17 Appendix
17.1 Scope of the report
17.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
17.3 Currency conversion rates for US$
Currency conversion rates for US$
17.4 Research methodology
Research methodology
17.5 Data procurement
Information sources
17.6 Data validation
Data validation
17.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
17.8 Data synthesis
Data synthesis
17.9 360 degree market analysis
360 degree market analysis
17.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Indication
Exhibits 6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 8: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 9: Executive Summary - Chart on Incremental Growth
Exhibits 10: Executive Summary - Data Table on Incremental Growth
Exhibits 11: Executive Summary - Chart on Company Market Positioning
Exhibits 12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 13: Overview on criticality of inputs and factors of differentiation
Exhibits 14: Overview on factors of disruption
Exhibits 15: Impact of drivers and challenges in 2024 and 2029
Exhibits 16: Parent Market
Exhibits 17: Data Table on - Parent Market
Exhibits 18: Market characteristics analysis
Exhibits 19: Value chain analysis
Exhibits 20: Offerings of companies included in the market definition
Exhibits 21: Market segments
Exhibits 22: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 24: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 26: Historic Market Size - Data Table on Global Neurodegenerative Diseases Therapeutics Market 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Indication Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits 31: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 32: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 33: Five forces analysis - Comparison between 2024 and 2029
Exhibits 34: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 35: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 37: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 38: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 39: Chart on Market condition - Five forces 2024 and 2029
Exhibits 40: Chart on Indication - Market share 2024-2029 (%)
Exhibits 41: Data Table on Indication - Market share 2024-2029 (%)
Exhibits 42: Chart on Comparison by Indication
Exhibits 43: Data Table on Comparison by Indication
Exhibits 44: Chart on Multiple sclerosis - Market size and forecast 2024-2029 ($ million)
Exhibits 45: Data Table on Multiple sclerosis - Market size and forecast 2024-2029 ($ million)
Exhibits 46: Chart on Multiple sclerosis - Year-over-year growth 2024-2029 (%)
Exhibits 47: Data Table on Multiple sclerosis - Year-over-year growth 2024-2029 (%)
Exhibits 48: Chart on Alzheimers disease - Market size and forecast 2024-2029 ($ million)
Exhibits 49: Data Table on Alzheimers disease - Market size and forecast 2024-2029 ($ million)
Exhibits 50: Chart on Alzheimers disease - Year-over-year growth 2024-2029 (%)
Exhibits 51: Data Table on Alzheimers disease - Year-over-year growth 2024-2029 (%)
Exhibits 52: Chart on Parkinsons disease - Market size and forecast 2024-2029 ($ million)
Exhibits 53: Data Table on Parkinsons disease - Market size and forecast 2024-2029 ($ million)
Exhibits 54: Chart on Parkinsons disease - Year-over-year growth 2024-2029 (%)
Exhibits 55: Data Table on Parkinsons disease - Year-over-year growth 2024-2029 (%)
Exhibits 56: Chart on Huntingtons disease - Market size and forecast 2024-2029 ($ million)
Exhibits 57: Data Table on Huntingtons disease - Market size and forecast 2024-2029 ($ million)
Exhibits 58: Chart on Huntingtons disease - Year-over-year growth 2024-2029 (%)
Exhibits 59: Data Table on Huntingtons disease - Year-over-year growth 2024-2029 (%)
Exhibits 60: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 61: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 62: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 63: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 64: Market opportunity by Indication ($ million)
Exhibits 65: Data Table on Market opportunity by Indication ($ million)
Exhibits 66: Chart on Drug Class - Market share 2024-2029 (%)
Exhibits 67: Data Table on Drug Class - Market share 2024-2029 (%)
Exhibits 68: Chart on Comparison by Drug Class
Exhibits 69: Data Table on Comparison by Drug Class
Exhibits 70: Chart on Immunomodulators - Market size and forecast 2024-2029 ($ million)
Exhibits 71: Data Table on Immunomodulators - Market size and forecast 2024-2029 ($ million)
Exhibits 72: Chart on Immunomodulators - Year-over-year growth 2024-2029 (%)
Exhibits 73: Data Table on Immunomodulators - Year-over-year growth 2024-2029 (%)
Exhibits 74: Chart on Interferons - Market size and forecast 2024-2029 ($ million)
Exhibits 75: Data Table on Interferons - Market size and forecast 2024-2029 ($ million)
Exhibits 76: Chart on Interferons - Year-over-year growth 2024-2029 (%)
Exhibits 77: Data Table on Interferons - Year-over-year growth 2024-2029 (%)
Exhibits 78: Chart on Decarboxylase inhibitors - Market size and forecast 2024-2029 ($ million)
Exhibits 79: Data Table on Decarboxylase inhibitors - Market size and forecast 2024-2029 ($ million)
Exhibits 80: Chart on Decarboxylase inhibitors - Year-over-year growth 2024-2029 (%)
Exhibits 81: Data Table on Decarboxylase inhibitors - Year-over-year growth 2024-2029 (%)
Exhibits 82: Chart on Dopamine agonists - Market size and forecast 2024-2029 ($ million)
Exhibits 83: Data Table on Dopamine agonists - Market size and forecast 2024-2029 ($ million)
Exhibits 84: Chart on Dopamine agonists - Year-over-year growth 2024-2029 (%)
Exhibits 85: Data Table on Dopamine agonists - Year-over-year growth 2024-2029 (%)
Exhibits 86: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 87: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 88: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 89: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 90: Market opportunity by Drug Class ($ million)
Exhibits 91: Data Table on Market opportunity by Drug Class ($ million)
Exhibits 92: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits 93: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits 94: Chart on Comparison by Route of Administration
Exhibits 95: Data Table on Comparison by Route of Administration
Exhibits 96: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 97: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 98: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 99: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 100: Chart on Injection - Market size and forecast 2024-2029 ($ million)
Exhibits 101: Data Table on Injection - Market size and forecast 2024-2029 ($ million)
Exhibits 102: Chart on Injection - Year-over-year growth 2024-2029 (%)
Exhibits 103: Data Table on Injection - Year-over-year growth 2024-2029 (%)
Exhibits 104: Chart on Transdermal - Market size and forecast 2024-2029 ($ million)
Exhibits 105: Data Table on Transdermal - Market size and forecast 2024-2029 ($ million)
Exhibits 106: Chart on Transdermal - Year-over-year growth 2024-2029 (%)
Exhibits 107: Data Table on Transdermal - Year-over-year growth 2024-2029 (%)
Exhibits 108: Market opportunity by Route of Administration ($ million)
Exhibits 109: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 110: Chart on End-user - Market share 2024-2029 (%)
Exhibits 111: Data Table on End-user - Market share 2024-2029 (%)
Exhibits 112: Chart on Comparison by End-user
Exhibits 113: Data Table on Comparison by End-user
Exhibits 114: Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits 116: Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits 117: Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits 118: Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits 120: Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits 121: Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits 122: Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits 124: Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits 125: Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits 126: Market opportunity by End-user ($ million)
Exhibits 127: Data Table on Market opportunity by End-user ($ million)
Exhibits 128: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 129: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 130: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 131: Chart on Geographic comparison
Exhibits 132: Data Table on Geographic comparison

Executive Summary

The following companies are recognized as the key players in the global neurodegenerative diseases therapeutics market: AB Science SA, AbbVie Inc., Acadia Pharmaceuticals Inc., AstraZeneca Plc, Biogen Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, H Lundbeck AS, Johnson and Johnson Services Inc., Merck and Co. Inc., Mitsubishi Chemical Corp., Novartis AG, Pfizer Inc., Sanofi SA, and Teva Pharmaceutical Industries Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increase in aging population."

According to the report, one of the major drivers for this market is the strong drug development pipeline.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AB Science SA
  • AbbVie Inc.
  • Acadia Pharmaceuticals Inc.
  • AstraZeneca Plc
  • Biogen Inc.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • H Lundbeck AS
  • Johnson and Johnson Services Inc.
  • Merck and Co. Inc.
  • Mitsubishi Chemical Corp.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.

Related Topics

Related Reports

Neurodegenerative Drugs Market by Type, Drug Class, Mode Of Administration, Mechanism Of Action, Therapeutic Approach, Indication, Patient Demographics, Sales Channel, End User - Global Forecast to 2030 - Product Image

Neurodegenerative Drugs Market by Type, Drug Class, Mode Of Administration, Mechanism Of Action, Therapeutic Approach, Indication, Patient Demographics, Sales Channel, End User - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Neurodegenerative Disorder Therapeutics Market Report 2025 - Product Image

Neurodegenerative Disorder Therapeutics Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Neurodegenerative Diseases Drugs Market Report and Forecast 2024-2032 - Product Image

Neurodegenerative Diseases Drugs Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Neurodegenerative Diseases Therapeutics - Global Strategic Business Report - Product Image

Neurodegenerative Diseases Therapeutics - Global Strategic Business Report

  • Report
  • 387 Pages
  • Global
From
Neurodegenerative Drugs - Global Strategic Business Report - Product Image

Neurodegenerative Drugs - Global Strategic Business Report

  • Report
  • 376 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.